Abstract
Ibuprofen arginine (IBA) combines well-established analgesic and anti-inflammatory properties with enhanced pharmacokinetics. The addition of arginine significantly improves solubility and absorption, leading to a faster onset of action compared to conventional ibuprofen. Clinical studies consistently demonstrate that IBA achieves meaningful pain relief within a shorter timeframe while maintaining a favorable safety profile. IBA’s rapid action is particularly valuable in managing acute exacerbations of chronic pain and preventing central sensitization, thus improving patient comfort, adherence, and overall quality of life. By addressing both the inflammatory and nociceptive components of pain, IBA offers an effective and well-tolerated alternative in multimodal pain management strategies. This review explores the clinical benefits of IBA in pain management among various clinical settings.
Author supplied keywords
Cite
CITATION STYLE
Sarzi-Puttini, P., Perrot, S., Perez-Cajaraville, J., Fornasari, D. M. M., Radaelli, F., & Varrassi, G. (2025, June 1). Clinical Benefits of Ibuprofen Arginine: A Narrative Review. Pain and Therapy. Adis. https://doi.org/10.1007/s40122-025-00735-5
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.